GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001067) » Definitions » Issuance of Debt

JW Pharmaceutical (XKRX:001067) Issuance of Debt : ₩104,737 Mil (TTM As of Dec. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Issuance of Debt?

JW Pharmaceutical's Issuance of Debt for the three months ended in Dec. 2024 was ₩38,000 Mil.

JW Pharmaceutical's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩104,737 Mil.

JW Pharmaceutical Issuance of Debt Historical Data

The historical data trend for JW Pharmaceutical's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Issuance of Debt Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 164,683.22 135,618.52 140,481.10 288,041.95 129,838.71

JW Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99,880.63 24,000.00 28,958.15 13,778.53 38,000.00

JW Pharmaceutical Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩104,737 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical Issuance of Debt Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001067) » Definitions » Issuance of Debt
Comparable Companies
XKRX:206650 XKRX:084110 XKRX:041960 XKRX:220100 XKRX:170900 XKRX:047920 XKRX:200670 XKRX:000640 XKRX:019170 XKRX:003520 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
001065.PFD:Korea 001060:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines